Advertisement

Topics

Brain Cancer: Epidemiology Forecast to 2027 [Report Updated: 24102018] Prices from USD $3396

10:38 EST 6 Dec 2018 | BioPortfolio Report Blog

Brain Cancer: Epidemiology Forecast to 2027


Summary


Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system CNS, which consists of the brain and spinal cord, including the brain stem. The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth. Only malignant tumors are designated as cancer. Primary brain tumors are those that start in the brain and may, in time, migrate elsewhere in the body, while metastatic brain tumors are those that start elsewhere in the body and migrate to the brain or other parts of the CNS.


GlobalData epidemiologists provide a 10year epidemiological forecast for the diagnosed incident cases of brain cancer by age and sex, the fiveyear diagnosed prevalent cases of brain cancer, the diagnosed incident cases of brain cancer by type, and the diagnosed incident cases of brain cancer with associated biomarkers.


In the 8MM, GlobalData epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an Annual Growth Rate AGR of 2.62%. The fiveyear diagnosed prevalent cases of brain cancer are also expected to increase from 220,839 cases in 2017 to 262,409 cases in 2027, at an AGR of 1.88% in the same time period.


Scope


The brain cancer Epidemiology Forecast Report provides an overview of the risk factors and global trends brain cancer in the eight major markets 8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China.

This report also includes a 10year epidemiological forecast for the following segmentations in all ages across the 8MM: diagnosed incident cases of brain cancer; fiveyear diagnosed prevalent cases; diagnosed incident cases of brain cancer type; and diagnosed incident cases of brain cancer with associated biomarkers.

The brain cancer epidemiology forecast report is written and developed by Masters and PhDlevel epidemiologists.

The Epidemiology Forecast Report is indepth, high quality, transparent, and marketdriven, providing expert analysis of disease trends in the 8MM.


Reasons to buy


The Brain Cancer Epidemiology Forecast report will allow you to

Develop business strategies by understanding the trends shaping and driving the global brain cancer market.

Quantify patient populations in the global brain cancer market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for brain cancer therapeutics in each of the markets covered.

Understand magnitude of brain cancer population by associated biomarkers.

Original Article: Brain Cancer: Epidemiology Forecast to 2027 [Report Updated: 24102018] Prices from USD $3396

NEXT ARTICLE

More From BioPortfolio on "Brain Cancer: Epidemiology Forecast to 2027 [Report Updated: 24102018] Prices from USD $3396"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Brain Cancer
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...